Orysia Bezpalko
Orysia Bezpalko has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
Bert W. O'MAlley
Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
2 shared publicationsDanish A. Nagda
Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
2 shared publicationsHillary Hei
Department of Infection Prevention and Control, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
2 shared publicationsJulia S. Sammons
Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia
2 shared publicationsLakshmi Srinivasan
Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia
2 shared publicationsShayanne A. Lajud
Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
2 shared publications
Latest Publications
- 30 June 2026
- Published by Wolters Kluwer Health in Journal of Patient Safety
Responsive Learning and Proactive Harm Prevention: Development of a Tiered Event Review Continuum
Objectives: Efforts to reduce health care-associated conditions (HACs) have increased over time, with notable success. Still, opportunities remain to reduce preventable harm in hospitalized children. The integration of both retrospective and proactive safety frameworks can enhance these efforts. We aimed to optimize our ability to learn from and prevent events of harm in hospitalized children at the Children’s Hospital of Philadelphia by developing and implementing a comprehensive, standardized tiered event review continuum. Methods: Using quality improvement methodologies, we launched a multiyear initiative to develop a standardized approach to HAC reviews, incorporating learning from events after they occur and proactive planning for at-risk patients before harm events. Measures included adherence to process, analysis of attendance trends, and longitudinal outcomes following reviews. Data were analyzed following full implementation of the review process, beginning in 2017. Results: From 2017 to 2023, 2217 retrospective reviews were completed with an adherence rate of 95%. Attendees were captured across disciplines, with a majority representing nursing. One thousand two hundred eighty-six proactive reviews were completed from January 2022 to June 2024; of these, 75% of patients did not experience a subsequent harm event during their hospitalization. Conclusions: We successfully developed and implemented a tiered event review framework that spanned the continuum of retrospective and proactive approaches to safety. This structure has been fully implemented with high reliability across all inpatient areas, and has yielded important insights in patient-level, unit-level, and system-level HAC improvement efforts. Future directions include enhancing provider engagement and better capturing the longitudinal impact of proactive safety huddles on patient outcomes.
- 30 June 2026
- Published by Wolters Kluwer Health in Journal of Patient Safety
Responsive Learning and Proactive Harm Prevention: Development of a Tiered Event Review Continuum
Objectives: Efforts to reduce health care-associated conditions (HACs) have increased over time, with notable success. Still, opportunities remain to reduce preventable harm in hospitalized children. The integration of both retrospective and proactive safety frameworks can enhance these efforts. We aimed to optimize our ability to learn from and prevent events of harm in hospitalized children at the Children’s Hospital of Philadelphia by developing and implementing a comprehensive, standardized tiered event review continuum. Methods: Using quality improvement methodologies, we launched a multiyear initiative to develop a standardized approach to HAC reviews, incorporating learning from events after they occur and proactive planning for at-risk patients before harm events. Measures included adherence to process, analysis of attendance trends, and longitudinal outcomes following reviews. Data were analyzed following full implementation of the review process, beginning in 2017. Results: From 2017 to 2023, 2217 retrospective reviews were completed with an adherence rate of 95%. Attendees were captured across disciplines, with a majority representing nursing. One thousand two hundred eighty-six proactive reviews were completed from January 2022 to June 2024; of these, 75% of patients did not experience a subsequent harm event during their hospitalization. Conclusions: We successfully developed and implemented a tiered event review framework that spanned the continuum of retrospective and proactive approaches to safety. This structure has been fully implemented with high reliability across all inpatient areas, and has yielded important insights in patient-level, unit-level, and system-level HAC improvement efforts. Future directions include enhancing provider engagement and better capturing the longitudinal impact of proactive safety huddles on patient outcomes.
- 17 June 2022
- Published by Elsevier in American Journal of Infection Control
- Vol. 51 (2) , 220-224
Surveillance and attribution of ambulatory central line-associated bloodstream infections in a pediatric healthcare system
- 17 June 2022
- Published by Elsevier in American Journal of Infection Control
- Vol. 51 (2) , 220-224
Surveillance and attribution of ambulatory central line-associated bloodstream infections in a pediatric healthcare system
- 1 March 2021
- Published by SAGE Publications in Ergonomics in Design: The Quarterly of Human Factors Applications
- Vol. 30 (1) , 4-10
All Hands on Deck: Sustaining Improved Hand Hygiene Compliance in the Operating Room
Hand hygiene is an essential component of infection prevention in the health care setting. Despite diligent efforts, clinicians can be susceptible to hand hygiene misses in fast-paced, complex environments such as the operating room due to systemic factors such as the physical environment, workflow, and sporadic interactions with other personnel. Through the use of human factors and resilience engineering concepts, work-as-done were studied to identify barriers to hand hygiene compliance in the operating rooms of a pediatric hospital in an urban area. The saliency, effort, expectancy, value model was applied to design a multifaceted intervention that resulted in a sustained 95% hand hygiene compliance.
- 1 March 2021
- Published by SAGE Publications in Ergonomics in Design: The Quarterly of Human Factors Applications
- Vol. 30 (1) , 4-10
All Hands on Deck: Sustaining Improved Hand Hygiene Compliance in the Operating Room
Hand hygiene is an essential component of infection prevention in the health care setting. Despite diligent efforts, clinicians can be susceptible to hand hygiene misses in fast-paced, complex environments such as the operating room due to systemic factors such as the physical environment, workflow, and sporadic interactions with other personnel. Through the use of human factors and resilience engineering concepts, work-as-done were studied to identify barriers to hand hygiene compliance in the operating rooms of a pediatric hospital in an urban area. The saliency, effort, expectancy, value model was applied to design a multifaceted intervention that resulted in a sustained 95% hand hygiene compliance.
- 5 November 2019
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 41 (1) , 67-72
Novel risk factors for central-line associated bloodstream infections in critically ill children
Objective: Central-line–associated bloodstream infections (CLABSI) cause morbidity and mortality in critically ill children. We examined novel and/or modifiable risk factors for CLABSI to identify new potential targets for infection prevention strategies.Methods: This single-center retrospective matched case-control study of pediatric intensive care unit (PICU) patients was conducted in a 60-bed PICU from April 1, 2013, to December 31, 2017. Case patients were in the PICU, had a central venous catheter (CVC), and developed a CLABSI. Control patients were in the PICU for ≥2 days, had a CVC for ≥3 days, and did not develop a CLABSI. Cases and controls were matched 1:4 on age, number of complex chronic conditions, and hospital length of stay.Results: Overall, 72 CLABSIs were matched to 281 controls. Univariate analysis revealed 14 risk factors, and 4 remained significant in multivariable analysis: total number of central line accesses in the 3 days preceding CLABSI (80+ accesses: OR, 4.8;P= .01), acute behavioral health needs (OR, 3.2;P= .02), CVC duration >7 days (8–14 days: OR, 4.2;P= .01; 15–29 days: OR, 9.8;P< .01; 30–59 days: OR, 17.3;P< .01; 60–89 days: OR, 39.8;P< .01; 90+ days: OR, 4.9;P= .01), and hematologic/immunologic disease (OR, 1.5;P= .05).Conclusions: Novel risk factors for CLABSI in PICU patients include acute behavioral health needs and >80 CVC accesses in the 3 days before CLABSI. Interventions focused on these factors may reduce CLABSIs in this high-risk population.
- 5 November 2019
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 41 (1) , 67-72
Novel risk factors for central-line associated bloodstream infections in critically ill children
Objective: Central-line–associated bloodstream infections (CLABSI) cause morbidity and mortality in critically ill children. We examined novel and/or modifiable risk factors for CLABSI to identify new potential targets for infection prevention strategies.Methods: This single-center retrospective matched case-control study of pediatric intensive care unit (PICU) patients was conducted in a 60-bed PICU from April 1, 2013, to December 31, 2017. Case patients were in the PICU, had a central venous catheter (CVC), and developed a CLABSI. Control patients were in the PICU for ≥2 days, had a CVC for ≥3 days, and did not develop a CLABSI. Cases and controls were matched 1:4 on age, number of complex chronic conditions, and hospital length of stay.Results: Overall, 72 CLABSIs were matched to 281 controls. Univariate analysis revealed 14 risk factors, and 4 remained significant in multivariable analysis: total number of central line accesses in the 3 days preceding CLABSI (80+ accesses: OR, 4.8;P= .01), acute behavioral health needs (OR, 3.2;P= .02), CVC duration >7 days (8–14 days: OR, 4.2;P= .01; 15–29 days: OR, 9.8;P< .01; 30–59 days: OR, 17.3;P< .01; 60–89 days: OR, 39.8;P< .01; 90+ days: OR, 4.9;P= .01), and hematologic/immunologic disease (OR, 1.5;P= .05).Conclusions: Novel risk factors for CLABSI in PICU patients include acute behavioral health needs and >80 CVC accesses in the 3 days before CLABSI. Interventions focused on these factors may reduce CLABSIs in this high-risk population.
- Open Access
- 26 November 2018
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 5 (suppl_1) , S346
1152. Leveraging Human Factors Engineering to Optimize Low-level Disinfection of Bedside Medical Tools
Background Inadequate cleaning and disinfection of shared medical equipment can lead to healthcare-associated infections and outbreaks. Stethoscopes were identified as the most commonly used piece of shared equipment at our institution, but cleaning practices were inconsistent among providers. We aimed to assess provider attitudes and practices around stethoscope disinfection and to subsequently implement a test of change (TOC) supported by human factors observations to improve cleaning consistency and frequency. Methods We conducted an anonymous electronic survey via SurveyMonkey paired with human factors observations in a free-standing children’s hospital. We surveyed physicians, nurses, and advanced practice providers to identify barriers to regular stethoscope cleaning. Quantitative results, human factors observations, and workflow simulations on a single unit were used to design an intervention to standardize low-level disinfection. Small mesh baskets holding alcohol prep pads labeled with brightly colored signage were installed by the exit of each patient room on one trial unit. Following implementation, a postsurvey and direct observations on the unit were conducted. Results Of those surveyed healthcare providers who completed the pre-survey (n = 383), 92% believed stethoscopes pose an infection risk to patients. However, only 38% of respondents reported cleaning their stethoscope between patient encounters. The most cited barrier to cleaning was a lack of easily accessible cleaning product (49%). After the unit-based TOC, alcohol from baskets were utilized by 80% of the 25 surveyed providers; 74% reported increased frequency of cleaning due to accessibility. Additionally, the brightly colored signage was a visual cue to disinfect equipment. Increased satisfaction of families reinforced the behavior. Direct observations revealed an increased frequency of cleaning while qualitative interviews elicited increased awareness from staff. Conclusion Leveraging human factors engineering to inform the placement and design of easily accessible disinfection supplies correlated with increased frequency of stethoscope cleaning by healthcare providers. Future steps include implementation in all inpatient care areas. Disclosures All authors: No reported disclosures.
- 26 November 2018
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 5 (suppl_1) , S346
Open Access1152. Leveraging Human Factors Engineering to Optimize Low-level Disinfection of Bedside Medical Tools
Background Inadequate cleaning and disinfection of shared medical equipment can lead to healthcare-associated infections and outbreaks. Stethoscopes were identified as the most commonly used piece of shared equipment at our institution, but cleaning practices were inconsistent among providers. We aimed to assess provider attitudes and practices around stethoscope disinfection and to subsequently implement a test of change (TOC) supported by human factors observations to improve cleaning consistency and frequency. Methods We conducted an anonymous electronic survey via SurveyMonkey paired with human factors observations in a free-standing children’s hospital. We surveyed physicians, nurses, and advanced practice providers to identify barriers to regular stethoscope cleaning. Quantitative results, human factors observations, and workflow simulations on a single unit were used to design an intervention to standardize low-level disinfection. Small mesh baskets holding alcohol prep pads labeled with brightly colored signage were installed by the exit of each patient room on one trial unit. Following implementation, a postsurvey and direct observations on the unit were conducted. Results Of those surveyed healthcare providers who completed the pre-survey (n = 383), 92% believed stethoscopes pose an infection risk to patients. However, only 38% of respondents reported cleaning their stethoscope between patient encounters. The most cited barrier to cleaning was a lack of easily accessible cleaning product (49%). After the unit-based TOC, alcohol from baskets were utilized by 80% of the 25 surveyed providers; 74% reported increased frequency of cleaning due to accessibility. Additionally, the brightly colored signage was a visual cue to disinfect equipment. Increased satisfaction of families reinforced the behavior. Direct observations revealed an increased frequency of cleaning while qualitative interviews elicited increased awareness from staff. Conclusion Leveraging human factors engineering to inform the placement and design of easily accessible disinfection supplies correlated with increased frequency of stethoscope cleaning by healthcare providers. Future steps include implementation in all inpatient care areas. Disclosures All authors: No reported disclosures.
- 20 July 2018
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 39 (9) , 1086-1092
Development of a novel prevention bundle for pediatric healthcare-associated viral infections
Objective: To reduce the healthcare-associated viral infection (HAVI) rate to 0.70 infections or fewer per 1,000 patient days by developing and sustaining a comprehensive prevention bundle.Setting: A 546-bed quaternary-care children’s hospital situated in a large urban area.Patients: Inpatients with a confirmed HAVI were included. These HAVIs were identified through routine surveillance by infection preventionists and were confirmed using National Healthcare Safety Network definitions for upper respiratory infections (URIs), pneumonia, and gastroenteritis.Methods: Quality improvement (QI) methods and statistical process control (SPC) analyses were used in a retrospective observational analysis of HAVI data from July 2012 through June 2016.Results: In total, 436 HAVIs were identified during the QI initiative: 63% were URIs, 34% were gastrointestinal infections, and 2.5% were viral pneumonias. The most frequent pathogens were rhinovirus (n=171) and norovirus (n=83). Our SPC analysis of HAVI rate revealed a statistically significant reduction in March 2014 from a monthly average of 0.81 to 0.60 infections per 1,000 patient days. Among HAVIs with event reviews completed, 15% observed contact with a sick primary caregiver and 15% reported contact with a sick visitor. Patient outcomes identified included care escalation (37%), transfer to ICU (11%), and delayed discharge (19%).Conclusions: The iterative development, implementation, and refinement of targeted prevention practices was associated with a significant reduction in pediatric HAVI. These practices were ultimately formalized into a comprehensive prevention bundle and provide an important framework for both patient and systems-level interventions that can be applied year-round and across inpatient areas.
- 20 July 2018
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 39 (9) , 1086-1092
Development of a novel prevention bundle for pediatric healthcare-associated viral infections
Objective: To reduce the healthcare-associated viral infection (HAVI) rate to 0.70 infections or fewer per 1,000 patient days by developing and sustaining a comprehensive prevention bundle.Setting: A 546-bed quaternary-care children’s hospital situated in a large urban area.Patients: Inpatients with a confirmed HAVI were included. These HAVIs were identified through routine surveillance by infection preventionists and were confirmed using National Healthcare Safety Network definitions for upper respiratory infections (URIs), pneumonia, and gastroenteritis.Methods: Quality improvement (QI) methods and statistical process control (SPC) analyses were used in a retrospective observational analysis of HAVI data from July 2012 through June 2016.Results: In total, 436 HAVIs were identified during the QI initiative: 63% were URIs, 34% were gastrointestinal infections, and 2.5% were viral pneumonias. The most frequent pathogens were rhinovirus (n=171) and norovirus (n=83). Our SPC analysis of HAVI rate revealed a statistically significant reduction in March 2014 from a monthly average of 0.81 to 0.60 infections per 1,000 patient days. Among HAVIs with event reviews completed, 15% observed contact with a sick primary caregiver and 15% reported contact with a sick visitor. Patient outcomes identified included care escalation (37%), transfer to ICU (11%), and delayed discharge (19%).Conclusions: The iterative development, implementation, and refinement of targeted prevention practices was associated with a significant reduction in pediatric HAVI. These practices were ultimately formalized into a comprehensive prevention bundle and provide an important framework for both patient and systems-level interventions that can be applied year-round and across inpatient areas.
- 12 November 2016
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 56 (3) , 268-277
A Pilot Randomized Trial of a Video Patient Decision Aid to Facilitate Early Intervention Referrals From Primary Care
Many young children identified with developmental concerns in pediatric settings do not receive early intervention (EI). We assessed the impact of a video decision aid and text message reminder on knowledge and attitudes regarding developmental delay and EI as well as referral completion. We conducted a pilot randomized controlled trial in an urban setting and enrolled 64 parent-child dyads referred to EI. Compared with controls, participants who received the intervention demonstrated increased knowledge regarding developmental delay and EI as well as more favorable attitudes in certain topics. Although we did not find a significant difference between arms in EI intake and evaluation, we found a pattern suggestive of increased intake and evaluation among participants with low health literacy in the intervention arm. Additional study is needed to identify strategies that improve the EI referral process for families and to understand the potential targeted role for decision aids and text messages.
- 12 November 2016
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 56 (3) , 268-277
A Pilot Randomized Trial of a Video Patient Decision Aid to Facilitate Early Intervention Referrals From Primary Care
Many young children identified with developmental concerns in pediatric settings do not receive early intervention (EI). We assessed the impact of a video decision aid and text message reminder on knowledge and attitudes regarding developmental delay and EI as well as referral completion. We conducted a pilot randomized controlled trial in an urban setting and enrolled 64 parent-child dyads referred to EI. Compared with controls, participants who received the intervention demonstrated increased knowledge regarding developmental delay and EI as well as more favorable attitudes in certain topics. Although we did not find a significant difference between arms in EI intake and evaluation, we found a pattern suggestive of increased intake and evaluation among participants with low health literacy in the intervention arm. Additional study is needed to identify strategies that improve the EI referral process for families and to understand the potential targeted role for decision aids and text messages.
- Open Access
- 14 December 2014
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 20 (24) , 6465-6478
Dual Disruption of DNA Repair and Telomere Maintenance for the Treatment of Head and Neck Cancer
Purpose: Poly(ADP-ribose) polymerases (PARP) and the Mre11, Rad50, and Nbs1 (MRN) complex are key regulators of DNA repair, and have been recently shown to independently regulate telomere length. Sensitivity of cancers to PARPi is largely dependent on the BRCAness of the cells. Unfortunately, the vast majority of cancers are BRCA-proficient. In this study, therefore, we investigated whether a targeted molecular “hit” on the MRN complex, which is upstream of BRCA, can effectively sensitize BRCA-proficient head and neck squamous cell carcinoma (HNSCC) to PARP inhibitor (PARPi). Experimental Design: Human HNSCC cell lines and a mouse model with HNSCC xenografts were used in this study. In vitro and in vivo studies were conducted to evaluate the effects and underlying mechanisms of dual molecular disruption of PARP and the MRN complex, using a pharmacologic inhibitor and a dominant-negative Nbs1 expression vector, respectively. Results: Our findings demonstrate that downregulation of the MRN complex disrupts homologous recombination, and, when combined with PARPi, leads to accumulation of lethal DNA double-strand breaks. Moreover, we show that PARPi and MRN complex disruption induces significantly shortening telomere length. Together, our results demonstrate that dual disruption of these pathways causes significant cell death in BRCA-proficient tumor cells both in vitro and in vivo. Conclusion: Our study, for the first time, elucidates a novel mechanism for MRN complex and PARP inhibition beyond DNA repair, demonstrating the feasibility of a dual disruption approach that extends the utility of PARPi to the treatment of BRCA-proficient cancers. Clin Cancer Res; 20(24); 6465–78. ©2014 AACR.
- 14 December 2014
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 20 (24) , 6465-6478
Open AccessDual Disruption of DNA Repair and Telomere Maintenance for the Treatment of Head and Neck Cancer
Purpose: Poly(ADP-ribose) polymerases (PARP) and the Mre11, Rad50, and Nbs1 (MRN) complex are key regulators of DNA repair, and have been recently shown to independently regulate telomere length. Sensitivity of cancers to PARPi is largely dependent on the BRCAness of the cells. Unfortunately, the vast majority of cancers are BRCA-proficient. In this study, therefore, we investigated whether a targeted molecular “hit” on the MRN complex, which is upstream of BRCA, can effectively sensitize BRCA-proficient head and neck squamous cell carcinoma (HNSCC) to PARP inhibitor (PARPi). Experimental Design: Human HNSCC cell lines and a mouse model with HNSCC xenografts were used in this study. In vitro and in vivo studies were conducted to evaluate the effects and underlying mechanisms of dual molecular disruption of PARP and the MRN complex, using a pharmacologic inhibitor and a dominant-negative Nbs1 expression vector, respectively. Results: Our findings demonstrate that downregulation of the MRN complex disrupts homologous recombination, and, when combined with PARPi, leads to accumulation of lethal DNA double-strand breaks. Moreover, we show that PARPi and MRN complex disruption induces significantly shortening telomere length. Together, our results demonstrate that dual disruption of these pathways causes significant cell death in BRCA-proficient tumor cells both in vitro and in vivo. Conclusion: Our study, for the first time, elucidates a novel mechanism for MRN complex and PARP inhibition beyond DNA repair, demonstrating the feasibility of a dual disruption approach that extends the utility of PARPi to the treatment of BRCA-proficient cancers. Clin Cancer Res; 20(24); 6465–78. ©2014 AACR.
- Open Access
- 25 February 2014
- Published by Springer Nature in British Journal of Cancer
- Vol. 110 (8) , 2116-2122
Biliverdin’s regulation of reactive oxygen species signalling leads to potent inhibition of proliferative and angiogenic pathways in head and neck cancer
In this study, we evaluate whether the use of biliverdin (BV), a natural non-toxic antioxidant product of haeme catabolism, can suppress head and neck squamous cell carcinoma (HNSCC) cell proliferation and improve the tumour survival both in vitro and in vivo. Furthermore, we investigate whether this therapeutic outcome relies on BV’s potent antioxidant effect on reactive oxygen species (ROS)-mediated signalling. Two well-characterised HNSCC cell lines and a mouse model with human HNSCC were used for this study. In vitro, the effect of BV on ROS was assayed. Subsequently, critical regulatory proteins involved in growth, antiapoptotic, and angiogenic pathways were investigated by western blot analysis. In addition, the antiproliferative effect of BV was also evaluated using the clonogenic assay. Moreover, tumour growth inhibition was assessed using a mouse model with HNSCC. Biliverdin treatment resulted in decreased ROS, leading to suppression of proliferation and angiogenesis pathways of HNSCC, significantly decreasing the expression and phosphorylation of oncogenic factors such as epidermal growth factor receptor (EGFR), phosphorylation of Akt, and expression of angiogenic marker and transcription factor, hypoxia-inducible factor1-α (HIF1-α). Furthermore, this downregulation of ROS by BV led to a significant suppression of tumour growth in vivo. Our study demonstrates the efficacy of a novel therapeutic approach using BV as an antitumour agent against HNSCC through its effect on EGFR/Akt and HIF1-α/angiogenesis signal transduction pathways. Our findings indicate that BV’s inhibitory effect on these tumorigenic pathways relies on its antioxidant effect, and may extend its therapeutic potential to other solid cancers.
- 25 February 2014
- Published by Springer Nature in British Journal of Cancer
- Vol. 110 (8) , 2116-2122
Open AccessBiliverdin’s regulation of reactive oxygen species signalling leads to potent inhibition of proliferative and angiogenic pathways in head and neck cancer
In this study, we evaluate whether the use of biliverdin (BV), a natural non-toxic antioxidant product of haeme catabolism, can suppress head and neck squamous cell carcinoma (HNSCC) cell proliferation and improve the tumour survival both in vitro and in vivo. Furthermore, we investigate whether this therapeutic outcome relies on BV’s potent antioxidant effect on reactive oxygen species (ROS)-mediated signalling. Two well-characterised HNSCC cell lines and a mouse model with human HNSCC were used for this study. In vitro, the effect of BV on ROS was assayed. Subsequently, critical regulatory proteins involved in growth, antiapoptotic, and angiogenic pathways were investigated by western blot analysis. In addition, the antiproliferative effect of BV was also evaluated using the clonogenic assay. Moreover, tumour growth inhibition was assessed using a mouse model with HNSCC. Biliverdin treatment resulted in decreased ROS, leading to suppression of proliferation and angiogenesis pathways of HNSCC, significantly decreasing the expression and phosphorylation of oncogenic factors such as epidermal growth factor receptor (EGFR), phosphorylation of Akt, and expression of angiogenic marker and transcription factor, hypoxia-inducible factor1-α (HIF1-α). Furthermore, this downregulation of ROS by BV led to a significant suppression of tumour growth in vivo. Our study demonstrates the efficacy of a novel therapeutic approach using BV as an antitumour agent against HNSCC through its effect on EGFR/Akt and HIF1-α/angiogenesis signal transduction pathways. Our findings indicate that BV’s inhibitory effect on these tumorigenic pathways relies on its antioxidant effect, and may extend its therapeutic potential to other solid cancers.
- 1 March 2013
- Published by Elsevier in Journal of Controlled Release
- Vol. 166 (3) , 268-276
A regulated delivery system for inner ear drug application
- 1 March 2013
- Published by Elsevier in Journal of Controlled Release
- Vol. 166 (3) , 268-276
A regulated delivery system for inner ear drug application